Our results indicated that p-Akt but not p-ERK was required for the degradation of PDCD4 upon serum stimulation, and thus PI3K-Akt pathway might play a direct role on the modulation of PDCD4 degradation in ovarian cancer cells. Here, MAPK1 is linked to ovarian cancer.